A detailed history of Wells Fargo & Company transactions in Brainsway Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 2,717 shares of BWAY stock, worth $26,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,717
Previous 70 3781.43%
Holding current value
$26,327
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.8 - $9.24 $15,352 - $24,458
2,647 Added 3781.43%
2,717 $25,000
Q1 2024

May 10, 2024

BUY
$5.25 - $7.46 $367 - $522
70 New
70 $0
Q3 2021

Nov 15, 2021

SELL
$7.4 - $10.2 $2,405 - $3,314
-325 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$8.25 - $11.62 $2,681 - $3,776
325 New
325 $3,000
Q2 2020

Aug 13, 2020

SELL
$5.89 - $8.55 $5,890 - $8,550
-1,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$5.23 - $12.31 $5,230 - $12,310
1,000 New
1,000 $8,000

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $160M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.